Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
about
Therapeutic interventions for symptomatic treatment in Huntington's diseaseThe most appropriate primary outcomes to design clinical trials on Huntington's disease: meta-analyses of cohort studies and randomized placebo-controlled trials.Understanding dystonia: diagnostic issues and how to overcome them.Psychophysiological aspects of Tourette's syndrome.Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393.Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
P2860
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
@ast
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
@en
type
label
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
@ast
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
@en
prefLabel
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
@ast
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
@en
P2093
P2860
P356
P1476
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
@en
P2093
P2860
P304
P356
10.1136/JNNP.52.5.631
P407
P577
1989-05-01T00:00:00Z